Beryl Drugs Share Price

BSE
17.88
-0.94 (5.71%)
BERLDRG • 24 Jun, 2025 | 03:28 PM
BUY

1Y Annualised Return

-43.75%

3Y Annualised Return

30.53%

5Y Annualised Return

18.74%

The current prices are delayed, login or Open Demat Account for live prices.

Beryl Drugs SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹52,59,319 (-19.09%)

Daily SIP of 25,000 would have become 52,59,319 in 1 year with a gain of -12,40,680 (-19.09%)

Beryl Drugs Stock Performance
Today’s Low - High
17.88
18.82
17.88
18.82
52 Week Low - High
17.35
46.00
17.35
46.00

Open

18.82

Prev. Close

18.82

Volume

100.00

Total Traded Value

1788.00

View details of Market Depth
Beryl Drugs Fundamental

Market Cap (in crs)

9.07

Face Value

10

Turnover (in lacs)

0.02

Key Metrics
Qtr Change %
Near 52W Low of ₹17.35
-23.3
Dividend yield 1yr %
0

Beryl Drugs Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Beryl Drugs Quarterly Revenue

Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017
4.73 Cr
3.63 Cr
3.24 Cr
4.88 Cr
2.51 Cr

Beryl Drugs Yearly Revenue

Mar 2018Mar 2017
15.99 Cr
11.53 Cr

Beryl Drugs Quarterly Net Profit/Loss

Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017
0.88 Cr
0.1 Cr
0.09 Cr
0.03 Cr
-0.02 Cr

Beryl Drugs Yearly Net Profit/Loss

Mar 2018Mar 2017
0.99 Cr
-0.41 Cr

Beryl Drugs shareholding Pattern

Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%
Promoter
26.4%
Public
73.6%

Beryl Drugs Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
17.88
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
18.70
10Day EMA
19.00
12Day EMA
19.00
20Day EMA
19.20
26Day EMA
19.40
50Day EMA
20.50
100Day EMA
23.50
200Day EMA
26.80
5Day SMA
18.80
10Day SMA
19.10
20Day SMA
19.10
30Day SMA
19.20
50Day SMA
20.10
100Day SMA
23.80
150Day SMA
27.70
200Day SMA
30.30
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
100 Rs
100 Rs
Week Rs
785 Rs
785 Rs
Month Rs
3015 Rs
3015 Rs
Resistance & Support
18.19
Pivot
Resistance
First Resistance
18.51
Second Resistance
19.13
Third Resistance
19.45
Support
First Support
17.57
Second support
17.25
Third Support
16.63
Relative Strength Index
35.77
Money Flow Index
80.79
MACD
-0.35
MACD Signal
-0.32
Average True Range
1.04
Average Directional Index
11.05
Rate of Change (21)
-10.38
Rate of Change (125)
-54.34

Beryl Drugs Latest News

31 MAY 2025 | Saturday

Beryl Drugs Ltd - 524606 - Announcement under Regulation 30 (LODR)-Newspaper Publication

30 MAY 2025 | Friday

Beryl Drugs Ltd - 524606 - AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2025

30 MAY 2025 | Friday

Beryl Drugs Ltd - 524606 - Board Meeting Outcome for OUTCOME OF BOARD MEETING

View More

Beryl Drugs Company background

Founded in: 1993
Managing director: Sanjay Sethi
Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERICEF injection, FNeuron, Amplicillin INJ, PMol, Biprox, BFlox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.

As of 24 Jun, 2025, Beryl Drugs share price is ₹17.9. The stock opened at ₹18.8 and had closed at ₹18.8 the previous day. During today’s trading session, Beryl Drugs share price moved between ₹17.88 and ₹18.82, with an average price for the day of ₹18.35. Over the last 52 weeks, the stock has recorded a low of ₹17.35 and a high of ₹46.00. In terms of performance, Beryl Drugs share price has declined by 49.5% over the past six months and has declined by 43.75% over the last year.

Read More

Beryl Drugs FAQs

You can easily buy Beryl Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Beryl Drugs stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -